News

Obesity drug prices are dropping, but getting a steady supply remains a challenge
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Obesity drug prices are dropping in US, but getting a steady supply remains a challenge
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
2 Stocks to Buy on the Dip and Hold for 10 Years
In the next 10 years, expect the company to do the same while benefiting from greater insurance coverage for CGM -- ...
Novo Nordisk's Sell-Off Has Gone Too Far
Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...